2024
Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement
Feroze R, Kang P, Dallan L, Akula N, Galo J, Yoon S, Ukaigwe A, Filby S, Baeza C, Pelletier M, Rushing G, Rajagopalan S, Al‐Kindi S, Rashid I, Attizzani G. Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement. Catheterization And Cardiovascular Interventions 2024, 104: 1119-1128. PMID: 38952304, DOI: 10.1002/ccd.31136.Peer-Reviewed Original ResearchMeSH KeywordsAction PotentialsAgedAged, 80 and overAortic ValveAortic Valve StenosisArea Under CurveAtrioventricular BlockBundle-Branch BlockCardiac Pacing, ArtificialFemaleFibrosisHeart Conduction SystemHumansMagnetic Resonance Imaging, CineMaleMyocardiumPacemaker, ArtificialPredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsROC CurveTime FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeConceptsTranscatheter aortic valve replacementCardiac magnetic resonance imagingLate gadolinium enhancementRight bundle branch blockArea under the receiver operating characteristic curveAortic valve replacementReceiver operating curveMyocardial fibrosisPost-TAVRConduction defectsBundle branch blockAssociations of myocardial fibrosisExtracellular volumeConduction diseaseValve replacementGadolinium enhancementPermanent pacemakerConduction abnormalitiesConduction deficitsHeart blockBranch blockRisk of heart blockSeptal late gadolinium enhancementMyocardial extracellular volume fractionBaseline conduction disease
2022
Risk Stratification of New Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
Tsushima T, Main A, Al-Kindi S, Dallan L, Wheat H, Baeza C, Pelletier M, Arruda M, Mackall J, Thal S, Ohno Y, Lee K, Siqueira D, Kaneko T, Harloff M, Costa G, Barbanti M, Attizzani G. Risk Stratification of New Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. The American Journal Of Cardiology 2022, 175: 80-87. PMID: 35597627, DOI: 10.1016/j.amjcard.2022.03.053.Peer-Reviewed Original ResearchConceptsLeft ventricular ejection fractionTranscatheter aortic valve implantationPersistent left bundle branch blockAssociated with cardiac mortalityNOP-LBBBLeft bundle branch blockLong-term outcomesBundle branch blockAortic valve implantationCardiac mortalityRisk stratificationComposite outcomeNew-onset persistent left bundle branch blockBranch blockValve implantationRetrospective study of patientsVentricular ejection fractionStudy of patientsHeart failure readmissionEjection fractionPermanent pacemakerRetrospective studyHeart failurePost-TAVIPatients
2020
Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk
Kolkailah A, Doukky R, Pelletier M, Volgman A, Kaneko T, Nabhan A. Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Heart 2020, 106: 1043-1045. PMID: 32482670, DOI: 10.1136/heartjnl-2020-316661.Peer-Reviewed Original ResearchRelationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes
Hirji S, McCarthy E, Kim D, McGurk S, Ejiofor J, Val F, Kolkailah A, Rosner B, Shook D, Nyman C, Berry N, Sobieszczyk P, Pelletier M, Shah P, O’Gara P, Kaneko T. Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes. JACC Cardiovascular Interventions 2020, 13: 335-343. PMID: 32029250, PMCID: PMC8858441, DOI: 10.1016/j.jcin.2019.09.048.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAortic ValveClinical CompetenceDatabases, FactualFemaleHeart Valve Prosthesis ImplantationHospitals, High-VolumeHospitals, Low-VolumeHumansMaleMedicareOutcome and Process Assessment, Health CareQuality Indicators, Health CareRisk AssessmentRisk FactorsTime FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeUnited StatesConceptsTranscatheter aortic valve replacementSurgical aortic valve replacementTranscatheter aortic valve replacement outcomesAortic valve replacementValve replacementConcomitant coronary artery bypass graft surgeryGroup 2Aortic valve replacement volumesGroup 1Group 3Group 4Surgical aortic valve replacement volumeCoronary artery bypass graft surgeryTranscatheter aortic valve replacement procedureArtery bypass graft surgeryAortic valve replacement proceduresYear post-procedureOpen-heart proceduresRisk-adjusted odds ratioMultivariate Cox regressionHeart valve proceduresLow-volume centersValve replacement proceduresTAVR admissionsBypass graft surgery
2019
Cardiac Surgery in Patients With Opioid Use Disorder: An Analysis of 1.7 Million Surgeries
Shah R, Hirji S, Percy E, Landino S, Yazdchi F, Bellavia A, Pelletier M, Shekar P, Kaneko T. Cardiac Surgery in Patients With Opioid Use Disorder: An Analysis of 1.7 Million Surgeries. The Annals Of Thoracic Surgery 2019, 109: 1194-1201. PMID: 31479643, DOI: 10.1016/j.athoracsur.2019.07.041.Peer-Reviewed Original ResearchConceptsOpioid use disorderCardiac surgeryIncreased risk of postoperative morbidityImpact of opioid use disorderRisk of postoperative morbidityOpioid epidemicAssociated with prolonged hospitalizationRisk factorsUse disorderOpioid use disorder statusCoronary artery bypass graftingNon-opioid usersPreoperative risk factorsCardiac surgery patientsPatient's preoperative risk factorsAcute kidney injuryArtery bypass graftingCardiac surgery outcomesIn-hospital mortalityCurrent opioid epidemicLonger hospital lengthImprove overall outcomesHigher hospital costsNational Inpatient SampleValve repairCharacterizing Risks Associated With Mitral Annular Calcification in Mitral Valve Replacement
Kaneko T, Hirji S, Percy E, Aranki S, McGurk S, Body S, Heydarpour M, Mallidi H, Singh S, Pelletier M, Rawn J, Shekar P. Characterizing Risks Associated With Mitral Annular Calcification in Mitral Valve Replacement. The Annals Of Thoracic Surgery 2019, 108: 1761-1767. PMID: 31207248, DOI: 10.1016/j.athoracsur.2019.04.080.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCalcinosisEchocardiography, TransesophagealFemaleFollow-Up StudiesHeart Valve DiseasesHeart Valve Prosthesis ImplantationHospital MortalityHumansIncidenceIntraoperative ComplicationsMaleMiddle AgedMitral ValvePostoperative ComplicationsRetrospective StudiesRisk AssessmentSeverity of Illness IndexSurvival RateUnited StatesConceptsMitral annular calcificationAssociated with increased operative mortalityPresence of mitral annular calcificationMV replacementOperative mortalityAnnular calcificationSociety of Thoracic Surgeons Adult Cardiac Surgery DatabaseMAC patientsAssociated with increased risk of acute kidney injuryAdult Cardiac Surgery DatabaseRisk of acute kidney injuryMitral valve (MVConcomitant tricuspid proceduresNon-MAC patientsObserved operative mortalityCardiac Surgery DatabaseMitral valve replacementAssociated with increased riskAdverse postoperative outcomesAcute kidney injuryIn-hospital complicationsTricuspid proceduresReoperation rateSurgery DatabaseValve replacement
2018
Mechanical Versus Bioprosthetic Aortic Valve Replacement in Patients Aged 50 Years and Younger
Hirji S, Kolkailah A, Ramirez-Del Val F, Lee J, McGurk S, Pelletier M, Singh S, Mallidi H, Aranki S, Shekar P, Kaneko T. Mechanical Versus Bioprosthetic Aortic Valve Replacement in Patients Aged 50 Years and Younger. The Annals Of Thoracic Surgery 2018, 106: 1113-1120. PMID: 29966596, DOI: 10.1016/j.athoracsur.2018.05.073.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsAortic Valve StenosisBioprosthesisCohort StudiesDatabases, FactualFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHospital MortalityHumansKaplan-Meier EstimateMaleMiddle AgedPostoperative ComplicationsPostoperative HemorrhagePrognosisPropensity ScoreProportional Hazards ModelsProsthesis DesignReoperationRetrospective StudiesRisk AssessmentSurvival AnalysisConceptsMechanical aortic valve replacementBioprosthetic AVRAortic valve replacementLong-term survivalOperative mortalityValve replacementRedo-AVRConcomitant coronary artery bypass graftingLong-term survival differenceEnd pointsIncreased risk of reoperationBioprosthetic aortic valve replacementCoronary artery bypass graftingMitral valve proceduresMedian observation timeSecondary end pointsMechanical aortic valve replacement patientsPrimary end pointRisk of reoperationArtery bypass graftingStudy evaluated outcomesValve proceduresBleeding incidenceYounger patientsSurvival differences
2017
Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement
Carreras E, Kaneko T, Val F, Pelletier M, Sobieszczyk P, Bhatt D, Shah P. Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement. Catheterization And Cardiovascular Interventions 2017, 91: 798-805. PMID: 28988432, PMCID: PMC5849510, DOI: 10.1002/ccd.27347.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAortic ValveAortic Valve StenosisBostonFemaleHeart FailureHospital MortalityHumansLength of StayMaleRecovery of FunctionRetrospective StudiesRisk AssessmentRisk FactorsSeverity of Illness IndexStroke VolumeTime FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeVentricular Dysfunction, LeftVentricular Function, LeftConceptsTranscatheter aortic valve replacementAortic valve replacementStroke volume indexHeart failureReduced LVEFValve replacementIncreased mortalityOutcomes similar to patientsTranscatheter aortic valve replacement patientsPredictor of 1-year mortalityAssociated with increased mortalityOutcomes of patientsLeft ventricular functionSimilar to patientsReduced EFVentricular functionLVEFClinical factorsWomen's HospitalVolume indexPatientsAssociated with increasesMortalityTranscatheterOutcomes
2008
Pneumatic Paracorporeal Ventricular Assist Device in Infants and Children: Initial Stanford Experience
Malaisrie S, Pelletier M, Yun J, Sharma K, Timek T, Rosenthal D, Wright G, Robbins R, Reitz B. Pneumatic Paracorporeal Ventricular Assist Device in Infants and Children: Initial Stanford Experience. The Journal Of Heart And Lung Transplantation 2008, 27: 173-177. PMID: 18267223, DOI: 10.1016/j.healun.2007.11.567.Peer-Reviewed Original ResearchMeSH KeywordsCardiomyopathy, DilatedCause of DeathEquipment DesignEquipment SafetyFemaleFollow-Up StudiesGraft RejectionGraft SurvivalHeart Defects, CongenitalHeart TransplantationHeart-Assist DevicesHumansInfantInfant, NewbornIntensive Care UnitsMaleRetrospective StudiesRisk AssessmentSurvival RateTreatment OutcomeWaiting ListsConceptsBerlin Heart ventricular assist deviceVentricular assist deviceBridge to transplantationLeft ventricular assist deviceBerlin Heart EXCOR Pediatric Ventricular Assist DeviceNeurological eventsEXCOR Pediatric ventricular assist deviceAnti-coagulationDevice exchangePlatelet-inhibiting strategiesCongenital heart diseaseSingle-center experienceIdiopathic dilated cardiomyopathyBody surface areaIntensive care unitMechanical circulatory supportParacorporeal ventricular assist deviceAssist deviceMultiple inotropesRestrictive cardiomyopathyCardiac failureDilated cardiomyopathyMedian weightBiventricular devicesGraft failure
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply